Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XERISTAR 90 MG CAPSULAS DURAS GASTRORRESISTENTES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/XERISTAR 90 MG CAPSULAS DURAS GASTRORRESISTENTES

Approved

STANDARD

XERISTAR 90 MG CAPSULAS DURAS GASTRORRESISTENTES

Esteve Pharmaceuticals S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 29, 2022
Approval ID: 83c4fd89ea2ce4a7
Company: Esteve Pharmaceuticals S.A.
Type: Standard

Approval Details

Approval Id: 83c4fd89ea2ce4a7
Drug Cima Aemps Name: XERISTAR 90 MG CAPSULAS DURAS GASTRORRESISTENTES
Register Number: 88003
Holder Company Name: Esteve Pharmaceuticals S.A.
Marketing Company Name: Esteve Pharmaceuticals S.A.
Holder Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Marketing Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Authorization Date: 2022-07-29
Dosage Form: CÁPSULA DURA GASTRORRESISTENTE
Dose: 90 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Esteve Pharmaceuticals S.A.
Company Detail Path: /organization/esteve-pharmaceuticals-s-a

Company Information

Pharmaceutical Company Name: Esteve Pharmaceuticals S.A.
Country Name: Spain
Website: http://www.esteve.com

Active Ingredients

DULOXETINA HIDROCLORURO

101,034 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 29, 2022

Approval ID

83c4fd89ea2ce4a7

Type

Standard

Back to CIMA-AEMPS Approvals